Ash Ola
8K posts

Ash Ola
@akinfermo
Software Engineer @Google. Private Pilot. Opinions my own.

O vídeo da mulher voando de paraglider sendo ATROPELADA por um avião cessna pqp












The US tech industry would be a shadow of itself without immigrants. First 10 examples that come to mind: 1. Elon Musk (South Africa) 2. Andrej Karpathy (Czechoslovakia) 3. Sergey Brin (Russia) 4. Jensen Huang (Taiwan) 5. Satya Nadella (India) 6. Ilya Sutskever (Russia) 7. Sundar Pichai (India) 8. Lisa Su (Taiwan) 9. Fei-Fei Li (China) 10. Sanjay Mehrotra (India)







JUST IN: SpaceX pledges to cover all power grid infrastructure upgrade costs associated with its data centers so those costs are not passed on to local households, per its S-1 filing.

Eli Lilly just released Phase 3 data for retatrutide, their next-generation obesity drug. 2,339 patients. 80 weeks. The biggest trial in the field. 8 things worth knowing: 1️⃣ It beats every obesity drug on the market. Wegovy (semaglutide): 15% Zepbound (tirzepatide): 22% Retatrutide: 25% 2️⃣ You don’t need the highest dose. The lowest (4mg) already outperforms Wegovy. 18% weight loss with one dose increase. Fewer people quit than on the sugar pill. 3️⃣ At two years, weight was still dropping. No plateau. Patients with BMI over 35 lost 84 pounds. 30% of their body weight. 4️⃣ Some patients stopped taking it because they lost too much weight. That’s never happened with an obesity drug. 5️⃣ It works differently. Ozempic and Zepbound suppress appetite. Retatrutide does that too, but its third receptor (glucagon) flips your metabolism toward burning stored fat. In Phase 2, ketone bodies rose 2-3x, confirming the body was switching fuel sources. 6️⃣ It causes a side effect no other obesity drug does: tingling and numbness (12.5%). New receptor, new trade-off. Worth watching. 7️⃣ In a separate study, it cleared 86% of liver fat. 93% of patients reached normal levels. 1 in 3 adults have fatty liver disease. No approved drug comes close. 8️⃣ Two-thirds of patients on the highest dose were reclassified out of obesity entirely. They started at BMI 40. They finished under 30. That’s not just weight loss. That’s a medical reclassification. @US_FDA filing expected late 2026.






TTM Net Income... Google $GOOGL: $160 Billion Nvidia $NVDA: $159 Billion Apple $AAPL: $123 Billion Microsoft $MSFT: $125 Billion Amazon $AMZN: $91 Billion Berkshire Hathaway $BRK.B: $73 Billion Meta $META: $71 Billion Russell 2000 (Combined) $IWM: -$16 Billion







